Citations (96)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Nikolaos Giannelos, Cheryl Ng & Desmond Curran. (2023) Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review. Human Vaccines & Immunotherapeutics 19:1.
Read now
Read now
Desmond Curran, Desirée Van Oorschot, Sean Matthews, Johannes Hain, Ahmed Ehab Salem & Magdalena Schwarz. (2021) Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany. Human Vaccines & Immunotherapeutics 17:12, pages 5296-5303.
Read now
Read now
Ulderico Freo, Patrizia Romualdi & Hans G Kress. (2019) Tapentadol for neuropathic pain: a review of clinical studies. Journal of Pain Research 12, pages 1537-1551.
Read now
Read now
Desmond Curran, Desirée Van Oorschot, Lijoy Varghese, Lidia Oostvogels, Tomas Mrkvan, Romulo Colindres, Alfred von Krempelhuber & Anastassia Anastassopoulou. (2017) Assessment of the potential public health impact of Herpes Zoster vaccination in Germany. Human Vaccines & Immunotherapeutics 13:10, pages 2213-2221.
Read now
Read now
Juan Wang & Yuyou Zhu. (2017) Different doses of gabapentin formulations for postherpetic neuralgia: A systematical review and meta-analysis of randomized controlled trials. Journal of Dermatological Treatment 28:1, pages 65-77.
Read now
Read now
Juan Luis Lopez-Belmonte, Ramón Cisterna, Angel Gil de Miguel, Caroline Guilmet, Florence Bianic & Mathieu Uhart. (2016) The use of Zostavax in Spain: the economic case for vaccination of individuals aged 50 years and older. Journal of Medical Economics 19:6, pages 576-586.
Read now
Read now
Roberto Casale, Maria Di Matteo, Cristina E Minella, Guido Fanelli & Massimo Allegri. (2014) Reduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case series. Journal of Pain Research 7, pages 353-357.
Read now
Read now
Timo Vesikari, Roland Hardt, Hans Rümke, Giancarlo Icardi, Jordi Montero, Stéphane Thomas, Christine Sadorge & Anne Fiquet. (2013) Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years: A randomized study of a single dose vs. two different two-dose schedules. Human Vaccines & Immunotherapeutics 9:4, pages 858-864.
Read now
Read now
Gordon A Irving & Michael Sweeney. (2012) Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia. Journal of Pain Research 5, pages 203-208.
Read now
Read now
Edward P. Armstrong, Daniel C. Malone, Bill McCarberg, Christopher J. Panarites & Sissi V. Pham. (2011) Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia. Current Medical Research and Opinion 27:5, pages 939-950.
Read now
Read now
L. Annemans, X. Bresse, C. Gobbo & M. Papageorgiou. (2010) Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium. Journal of Medical Economics 13:3, pages 537-551.
Read now
Read now
Robert W Johnson. (2010) Herpes zoster and postherpetic neuralgia. Expert Review of Vaccines 9:sup3, pages 21-26.
Read now
Read now
Articles from other publishers (84)
Jiayu Tang, Yunchao Zhang, Chenxin Liu, Anqi Zeng & Linjiang Song. (2023) Therapeutic Strategies for Postherpetic Neuralgia: Mechanisms, Treatments, and Perspectives. Current Pain and Headache Reports 27:9, pages 307-319.
Crossref
Crossref
Funda ERDURAN. (2023) Postherpetik Nevralji Tanısıyla Takip Edilen Hastaların Demografik ve Klinik Özelliklerinin DeğerlendirilmesiEvaluation of Demographic and Clinical Characteristics of the Patients with the Diagnosis of Postherpetic Neuralgia. Cumhuriyet Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 8:2, pages 157-161.
Crossref
Crossref
Miguel Á. Huerta, Miguel M. Garcia, Beliu García-Parra, Ancor Serrano-Afonso & Nancy Paniagua. (2023) Investigational Drugs for the Treatment of Postherpetic Neuralgia: Systematic Review of Randomized Controlled Trials. International Journal of Molecular Sciences 24:16, pages 12987.
Crossref
Crossref
Keiko Yamada, Yasuko Mori, Renzhe Cui, Yasuhiko Kubota, Hideo Asada, Yoshinobu Okuno, Koichi Yamanishi & Hiroyasu Iso. (2023) Predictors of herpes zoster severity and immune responses according to pain trajectories: A community‐based prospective cohort study. The Journal of Dermatology 50:8, pages 1020-1033.
Crossref
Crossref
Aiping Wang, Hang Li, Zhihong Xie, lingfeng Li, Xian Jiang, Qing Guo, Fengming Hu, Jianzhong Zhang, Yong Cui, Yangfeng Ding, Hong Fang, Xiuping Han, Shuping Guo, Junlong Wang & Na Ni. (2023) Randomized, Placebo-Controlled, Multicenter Clinical Study on the Efficacy and Safety of Lidocaine Patches in Chinese Patients with Postherpetic Neuralgia. Dermatology and Therapy 13:7, pages 1477-1487.
Crossref
Crossref
Jingyue Zhang, Juan Sun, Jiyu Kang, Huacheng Zhou & Liangjuan Ma. (2022) Efficacy of indwelling trocar therapy for postherpetic neuralgia: A retrospective study of an acupuncture method. Dermatologic Therapy 35:11.
Crossref
Crossref
Jae Hun Kim, Chang-Soon Lee, Woong Ki Han, Jun Bo Sim & Francis Sahngun Nahm. (2022) Determining the Definitive Time Criterion for Postherpetic Neuralgia Using Infrared Thermographic Imaging. Pain and Therapy 11:2, pages 591-600.
Crossref
Crossref
Liping Chen, Yaoyao Zhang, Yanru Chen, Ting Wang, Kai Sun, Hao Tang, Wen Shen & Fuhai Ji. (2022) Efficacy and Safety of Botulinum Toxin A and Pulsed Radiofrequency on Postherpetic Neuralgia: A Randomized Clinical Trial. Contrast Media & Molecular Imaging 2022, pages 1-9.
Crossref
Crossref
Jianqi Nie, Yang Sun, Kai Feng, Lingling Huang, Ye Li & Zhonghu Bai. (2022) The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process. Vaccine 40:13, pages 2036-2043.
Crossref
Crossref
Zhiyou Peng, Jianguo Guo, Yanfeng Zhang, Xuejiao Guo, Wenguang Huang, Yunze Li, Zhe Yan, Nannan Guo, Daqiang Ke, Li Chen, Jinyan Huang & Zhiying Feng. (2022) Development of a Model for Predicting the Effectiveness of Pulsed Radiofrequency on Zoster-Associated Pain. Pain and Therapy 11:1, pages 253-267.
Crossref
Crossref
Duc Thuan Nguyen, Thanh Chung Dang, Quang An Nguyen, Trung Duc Le, Thi Dung Hoang, Thi Ngoc Truong Tran, Ta Hai Ninh Duong, Van Tuan Nguyen, Van Quan Le, Tien Ung Hoang, Minh Tuan Duong, Dinh Son Nhu & Viet Nga Phan. (2021) The effect of subcutaneous injection of methylprednisolone acetate and lidocaine for refractory postherpetic neuralgia: a prospective, observational study. Health Science Reports 4:2.
Crossref
Crossref
Marcia M. L. Kho, Stefan Roest, Dominique M. Bovée, Herold J. Metselaar, Rogier A. S. Hoek, Annemiek A. van der Eijk, Olivier C. Manintveld, Joke I. Roodnat & Nicole M. van Besouw. (2021) Herpes Zoster in Solid Organ Transplantation: Incidence and Risk Factors. Frontiers in Immunology 12.
Crossref
Crossref
Song Wen, Qiu-Xia Xiao, Zhao-Qiong Zhu, Li Chen, Ying Li, Qi-Hua Ran, Song Cao & Liu-Lin Xiong. (2021) Application of Nalbuphine in Trigeminal Ganglion Pulse Radiofrequency Surgery in Patients with Postherpetic Neuralgia. Pain Research and Management 2021, pages 1-9.
Crossref
Crossref
Tianhao Li, Jundong Wang, Hongyan Xie, Pingsheng Hao, Chun Qing, Yuzhen Zhang, Xin Liao & Tao Liang. (2020) Study on the related factors of post‐herpetic neuralgia in hospitalized patients with herpes zoster in Sichuan Hospital of Traditional Chinese Medicine based on big data analysis. Dermatologic Therapy 33:6.
Crossref
Crossref
Andrew J. Goldsmith, Andrew S. Liteplo & Hamid Shokoohi. (2020) Ultrasound-Guided Serratus Anterior Plane Block for Intractable Herpes Zoster Pain in the Emergency Department. The Journal of Emergency Medicine 59:3, pages 409-412.
Crossref
Crossref
Huachong Xu, Yucong Shi, Pei Liu & Li Deng. (2020) Efficacy comparison of different acupuncture methods for herpes zoster. Medicine 99:26, pages e20833.
Crossref
Crossref
Eleni Papakonstantinou. (2020) Schwere Komplikationen verhindern. Der Deutsche Dermatologe 68:2, pages 116-125.
Crossref
Crossref
Mitra Saadatian-Elahi, Bernard Bauduceau, Corinne Del-Signore & Philippe Vanhems. (2020) Diabetes as a risk factor for herpes zoster in adults: A synthetic literature review. Diabetes Research and Clinical Practice 159, pages 107983.
Crossref
Crossref
Thomas J. Hong & Jonathan Chang. 2020. Pain Management for Clinicians. Pain Management for Clinicians
193
211
.
Nicola P. Klein, Joan Bartlett, Bruce Fireman, Morgan A. Marks, John Hansen, Edwin Lewis, Laurie Aukes & Patricia Saddier. (2019) Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention. Vaccine 37:36, pages 5422-5427.
Crossref
Crossref
Silvia Cocchio, Tatjana Baldovin, Patrizia Furlan, Chiara Bertoncello, Alessandra Buja, Mario Saia, Marco Fonzo & Vincenzo Baldo. (2018) Cross-sectional study on hospitalizations related to herpes zoster in an Italian region, 2008–2016. Aging Clinical and Experimental Research 31:1, pages 145-150.
Crossref
Crossref
Giovanni Rezza. 2019. Adult Vaccinations. Adult Vaccinations
19
24
.
Pieter T. de Boer, Alies van Lier, Hester de Melker, Albert J. M. van Wijck, Jan C. Wilschut, Albert Jan van Hoek & Maarten J. Postma. (2018) Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines. BMC Medicine 16:1.
Crossref
Crossref
Janne Gierthmühlen, Olga Braig, Stefanie Rehm, Jana Hellriegel, Andreas Binder & Ralf Baron. (2018) Dynamic of the somatosensory system in postherpetic neuralgia. PAIN Reports 3:6, pages e668.
Crossref
Crossref
Joke Bilcke, Frederik Verelst & Philippe Beutels. (2018) Sponsorship Bias in Base-Case Values and Uncertainty Bounds of Health Economic Evaluations? A Systematic Review of Herpes Zoster Vaccination. Medical Decision Making 38:6, pages 730-745.
Crossref
Crossref
Susanna Esposito, Elisabetta Franco, Gaetan Gavazzi, Angel Gil de Miguel, Roland Hardt, George Kassianos, Isabelle Bertrand, Marie-Cécile Levant, Benoit Soubeyrand & Jose Antonio López Trigo. (2018) The public health value of vaccination for seniors in Europe. Vaccine 36:19, pages 2523-2528.
Crossref
Crossref
Volker TronnierVolker Tronnier. 2018. Neurochirurgische Schmerztherapie. Neurochirurgische Schmerztherapie
267
337
.
. (2017) Background paper to the decision not to recommend a standard vaccination with the live attenuated herpes zoster vaccine for the elderly in Germany. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 60:10, pages 1162-1179.
Crossref
Crossref
Christoph Maier, Ralf Baron, Elena Enax-Krumova, Jule Frettlöh, Rudolf van Schayck & Tim Hagenacker. 2017. Schmerztherapie. Schmerztherapie
163
228
.
Giovanni Gabutti, Nicoletta Valente, Parvanè Kuhdari, Silvia Lupi & Armando Stefanati. (2016) Prevention of herpes zoster and its complications: from the clinic to the real-life experience with the vaccine. Journal of Medical Microbiology 65:12, pages 1363-1369.
Crossref
Crossref
Nicole M. van Besouw, Peter Th.W. van Hal, Joke M. Zuijderwijk, Ronella de Kuiper, Rogier A.S. Hoek, Jan J. van Weezel, Annemiek A. van der Eijk, Georges M.G.M. Verjans & Willem Weimar. (2016) Herpes zoster after lung transplantation boosts varicella zoster virus–specific adaptive immune responses. The Journal of Heart and Lung Transplantation 35:12, pages 1435-1442.
Crossref
Crossref
Esther Redondo Margüello, Dídac Mauricio, José Javier Mediavilla Bravo, Alfonso Soto González, Elías Delgado Álvarez, F. Javier Ampudia-Blasco & Esteban Jódar Gimeno. (2016) ZODIAC: Consenso para la prevención del herpes zóster en personas con diabetes mellitus. SEMERGEN - Medicina de Familia 42, pages 1-19.
Crossref
Crossref
Dong Hoon Lee, Ji Eun Park, Duck Mi Yoon, Kyung Bong Yoon, Kiwook Kim & Shin Hyung Kim. (2016) Factors Associated with Increased Risk for Clinical Insomnia in Patients with Postherpetic Neuralgia: A Retrospective Cross-Sectional Study. Pain Medicine 17:10, pages 1917-1922.
Crossref
Crossref
Hélène Bricout, Margaret Haugh, Olugbenga Olatunde & Ruth Gil Prieto. (2015) Herpes zoster-associated mortality in Europe: a systematic review. BMC Public Health 15:1.
Crossref
Crossref
Adam Gater, Mathieu Uhart, Rachael McCool & Emmanuelle Préaud. (2015) The humanistic, economic and societal burden of Herpes Zoster in Europe: a critical review. BMC Public Health 15:1.
Crossref
Crossref
Naum Shaparin, Patricia W. Slattum, Iwona Bucior & Srinivas Nalamachu. (2015) Relationships Among Adverse Events, Disease Characteristics, and Demographics in Treatment of Postherpetic Neuralgia With Gastroretentive Gabapentin. The Clinical Journal of Pain 31:11, pages 983-991.
Crossref
Crossref
Roy Freeman, Mark S. Wallace, Michael Sweeney & Misha M. Backonja. (2015) Relationships Among Pain Quality, Pain Impact, and Overall Improvement in Patients with Postherpetic Neuralgia Treated with Gastroretentive Gabapentin. Pain Medicine 16:10, pages 2000-2011.
Crossref
Crossref
Kosuke Kawai, Emmanouil Rampakakis, Tsen-Fang Tsai, Hee Jin Cheong, Jittima Dhitavat, Alejandro Ortiz Covarrubias, Lin Yang, Miguel Cashat-Cruz, Homero Monsanto, Kelly Johnson, John S. Sampalis & Camilo J. Acosta. (2015) Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia. International Journal of Infectious Diseases 34, pages 126-131.
Crossref
Crossref
Javier Diez-Domingo, Thomas Weinke, Juan Garcia de Lomas, Claudius U. Meyer, Isabelle Bertrand, Cécile Eymin, Stéphane Thomas & Christine Sadorge. (2015) Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: A randomised non-inferiority clinical trial. Vaccine 33:6, pages 789-795.
Crossref
Crossref
Lindsay Parker, Rachel Huelin, Zarmina Khankhel, Radek Wasiak & Joaquin Mould. (2015) A Systematic Review of Pharmacoeconomic Studies for Pregabalin. Pain Practice 15:1, pages 82-94.
Crossref
Crossref
Hélène Bricout, Emilia Perinetti, Paolo Marchettini, Pietro Ragni, Carla Maria Zotti, Giovanni Gabutti, Antonio Volpi & Elisabetta Franco. (2014) Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009–2010): a GP-based prospective cohort study. BMC Infectious Diseases 14:1.
Crossref
Crossref
Mick Serpell, Adam Gater, Stuart Carroll, Linda Abetz-Webb, Azharul Mannan & Robert Johnson. (2014) Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the zoster quality of life (ZQOL) study. Health and Quality of Life Outcomes 12:1.
Crossref
Crossref
Adam Gater, Linda Abetz-Webb, Stuart Carroll, Azharul Mannan, Mick Serpell & Robert Johnson. (2014) Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study. BMC Infectious Diseases 14:1.
Crossref
Crossref
Pei-Shan Tsai, Heng-Chia Chang & Chun-Jen Huang. (2014) Postherpetic neuralgia is associated with an increased risk of coronary heart disease: A population-based cohort study. International Journal of Cardiology 177:3, pages 1052-1053.
Crossref
Crossref
Timothy R. Deer, Nagy Mekhail, David Provenzano, Jason Pope, Elliot Krames, Michael Leong, Robert M. Levy, David Abejon, Eric Buchser, Allen Burton, Asokumar Buvanendran, Kenneth Candido, David Caraway, Michael Cousins, Michael DeJongste, Sudhir Diwan, Sam Eldabe, Kliment Gatzinsky, Robert D. Foreman, Salim Hayek, Philip Kim, Thomas Kinfe, David Kloth, Krishna Kumar, Syed Rizvi, Shivanand P. Lad, Liong Liem, Bengt Linderoth, Sean Mackey, Gladstone McDowell, Porter McRoberts, Lawrence Poree, Joshua Prager, Lou Raso, Richard Rauck, Marc Russo, Brian Simpson, Konstantin Slavin, Peter Staats, Michael Stanton-Hicks, Paul Verrills, Joshua Wellington, Kayode Williams & Richard North. (2014) The Appropriate Use of Neurostimulation of the Spinal Cord and Peripheral Nervous System for the Treatment of Chronic Pain and Ischemic Diseases: The Neuromodulation Appropriateness Consensus Committee. Neuromodulation: Technology at the Neural Interface 17:6, pages 515-550.
Crossref
Crossref
H. Fan, W. Yu, Q. Zhang, H. Cao, J. Li, J. Wang, Y. Shao & X. Hu. (2014) Efficacy and safety of gabapentin 1800 mg treatment for post-herpetic neuralgia: a meta-analysis of randomized controlled trials. Journal of Clinical Pharmacy and Therapeutics 39:4, pages 334-342.
Crossref
Crossref
K. Kawai, B. G. Gebremeskel & C. J. Acosta. (2014) Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 4:6, pages e004833-e004833.
Crossref
Crossref
Peng Wang, Jiping Zhao & Taixiang Wu. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Seung Min LeeJinwoong LimJae-Dong LeeDo-Young ChoiSanghoon Lee. (2014) Bee Venom Treatment for Refractory Postherpetic Neuralgia: A Case Report. The Journal of Alternative and Complementary Medicine 20:3, pages 212-214.
Crossref
Crossref
Kosuke Kawai, Emmanuelle Preaud, Florence Baron-Papillon, Nathalie Largeron & Camilo J. Acosta. (2014) Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review. Vaccine 32:15, pages 1645-1653.
Crossref
Crossref
Mimi Levine, Joshua E. Richardson, Evelyn Granieri & M. Cary Reid. (2014) Novel Telemedicine Technologies in Geriatric Chronic Non-Cancer Pain: Primary Care Providers’ Perspectives. Pain Medicine 15:2, pages 206-213.
Crossref
Crossref
Thomas Weinke, Andrea Glogger, Isabelle Bertrand & Kati Lukas. (2014) The Societal Impact of Herpes Zoster and Postherpetic Neuralgia on Patients, Life Partners, and Children of Patients in Germany. The Scientific World Journal 2014, pages 1-8.
Crossref
Crossref
Sybil Pinchinat, Ana M Cebrián-Cuenca, Hélène Bricout & Robert W Johnson. (2013) Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infectious Diseases 13:1.
Crossref
Crossref
Gérard Mick & Guy Hans. (2013) Postherpetic neuralgia in Europe: The scale of the problem and outlook for the future. Journal of Clinical Gerontology and Geriatrics 4:4, pages 102-108.
Crossref
Crossref
Anita Gupta & Sean Li. (2013) Safety and Efficacy of Once-Daily Gastroretentive Gabapentin in Patients with Postherpetic Neuralgia Aged 75 Years and Over. Drugs & Aging 30:12, pages 999-1008.
Crossref
Crossref
Wendy S. Hupp & F. John Firriolo. (2013) Cranial Neuralgias. Dental Clinics of North America 57:3, pages 481-495.
Crossref
Crossref
Christine N. Sang, Rekha Sathyanarayana & Michael Sweeney. (2013) Gastroretentive Gabapentin (G-GR) Formulation Reduces Intensity of Pain Associated With Postherpetic Neuralgia (PHN). The Clinical Journal of Pain 29:4, pages 281-288.
Crossref
Crossref
Jung Hun Kang & Eduardo Bruera. 2013. Cancer Pain. Cancer Pain
165
190
.
Mellar P. Davis & Geoffrey Mitchell. (2012) Reconstructing analgesic trials. Current Opinion in Supportive & Palliative Care 6:4, pages 490-493.
Crossref
Crossref
Harald Breivik. (2012) The life long burden of suffering from postherpetic neuralgia is reduced by adult vaccination and by topical anti-hyperalgesic treatment with lidocaine and capsaicin. Scandinavian Journal of Pain 3:4, pages 218-219.
Crossref
Crossref
Gordon Irving. (2012) Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians. Therapeutic Advances in Chronic Disease 3:5, pages 211-218.
Crossref
Crossref
Kati Lukas, Alexander Edte & Isabelle Bertrand. (2011) The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries. Journal of Public Health 20:4, pages 441-451.
Crossref
Crossref
Gordon Irving. (2012) Once-daily gastroretentive gabapentin for treatment of postherpetic neuralgia. Pain Management 2:3, pages 259-265.
Crossref
Crossref
Ruth Gil-Prieto, Alejandro Álvaro-Meca, Alba González-Escalada Mena, José María Guillén Ortega & Ángel Gil De Miguel. (2012) The Burden of Hospitalisations for Herpes Zoster Ophtalmicus in Spain (1997-2008). World Journal of Vaccines 02:03, pages 164-171.
Crossref
Crossref
Lynn R Webster, Margarita Nunez, Marvin D Tark, Edwin D Dunteman, Biao Lu, Jeffrey K Tobias & Geertrui F Vanhove. (2011) Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia. BMC Anesthesiology 11:1.
Crossref
Crossref
Miroslav M. Backonja, Daniel M. Canafax & Kenneth C. Cundy. (2011) Efficacy of Gabapentin Enacarbil vs Placebo in Patients with Postherpetic Neuralgia and a Pharmacokinetic Comparison with Oral Gabapentin. Pain Medicine 12:7, pages 1098-1108.
Crossref
Crossref
Christoph Maier, Ralf Baron, Jule Frettlöh, Rudolf van Schayck & Tim Hagenacker. 2011. Die Schmerztherapie. Die Schmerztherapie
141
218
.
Benoit Arnould, Khadra Benmedjahed, Jean-Luc Gallais, Patrick Giniès & Ralf Baron. (2010) The impact of herpes zoster and subsequent chronic pain on patients’ daily lives. Journal of Public Health 18:6, pages 567-574.
Crossref
Crossref
Mark S. Wallace, Gordon Irving & Verne E. Cowles. (2010) Gabapentin Extended-Release Tablets for the Treatment of Patients with Postherpetic Neuralgia. Clinical Drug Investigation 30:11, pages 765-776.
Crossref
Crossref
Miroslav M. Backonja. (2012) High‐concentration capsaicin for the treatment of post‐herpetic neuralgia and other types of peripheral neuropathic pain. European Journal of Pain Supplements 4:S2, pages 170-174.
Crossref
Crossref
Thomas R. Tölle. (2012) Challenges with current treatment of neuropathic pain. European Journal of Pain Supplements 4:S2, pages 161-165.
Crossref
Crossref
B. Namer. (2010) Age related changes in human C-fiber function. Neuroscience Letters 470:3, pages 185-187.
Crossref
Crossref
Gerry J.F. Saldanha. 2010. Brocklehurst's Textbook of Geriatric Medicine and Gerontology. Brocklehurst's Textbook of Geriatric Medicine and Gerontology
466
477
.
Ralf Baron, Thomas R. Tölle, Ulrich Gockel, Mathias Brosz & Rainer Freynhagen. (2009) A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms. Pain 146:1, pages 34-40.
Crossref
Crossref
John D. Markman & Ross S. Hanson. (2009) THE ROLE OF INTERVENTIONAL THERAPY IN THE TREATMENT OF NEUROPATHIC PAIN. CONTINUUM: Lifelong Learning in Neurology 15, pages 101-133.
Crossref
Crossref
Ngoc Quan Phan, Dorothee Siepmann, Ingrid Gralow & Sonja Ständer. (2009) Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia. Journal der Deutschen Dermatologischen Gesellschaft.
Crossref
Crossref
Dorothée Nashan, Frank Meiss & Ingrid Gralow. (2009) Pain: Basics and relevance in dermatology. Journal der Deutschen Dermatologischen Gesellschaft 7:8, pages 704-716.
Crossref
Crossref
Patricia Bruckenthal, M. Carrington Reid & Lori Reisner. (2009) Special Issues in the Management of Chronic Pain in Older Adults. Pain Medicine 10:suppl 2, pages S67-S78.
Crossref
Crossref
Sandrine I. Samson & Yves Mégard. (2013) Overview of vaccination policies for the elderly in Western European countries. Aging Clinical and Experimental Research 21:3, pages 210-215.
Crossref
Crossref
Peng Wang, Jiping Zhao & Taixiang Wu. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
B. Namer, B. Barta, K. Ørstavik, R. Schmidt, R. Carr, M. Schmelz & H. O. Handwerker. (2009) Microneurographic assessment of C-fibre function in aged healthy subjects. The Journal of Physiology 587:2, pages 419-428.
Crossref
Crossref
Christoph Maier, Ralf Baron, Jule Frettlöh, Rudolf H. van Schayck & Zaza Katsarava. 2009. Die Schmerztherapie. Die Schmerztherapie
141
217
.
Andreas Binder & Ralf Baron. (2008) Postherpetic neuralgia—fighting pain with fire. The Lancet Neurology 7:12, pages 1077-1078.
Crossref
Crossref
Robert W Johnson, Gunnar Wasner, Patricia Saddier & Ralf Baron. (2008) Herpes Zoster and Postherpetic Neuralgia. Drugs & Aging 25:12, pages 991-1006.
Crossref
Crossref